CBM588 in Improving Clinical Outcomes in Participants Who Have Undergone Donor Hematopoietic Stem Cell Transplant
Condition: Allogeneic Hematopoietic Stem Cell Transplantation Recipient Interventions: Other: Best Practice; Drug: CBM588 Sponsors: City of Hope Medical Center; National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials